Summary
Deployed physics-based AI simulations on cloud infrastructure to replace traditional laboratory-driven drug discovery cycles. Used large-scale molecular modeling to predict affinity and toxicity before synthesis. Accelerated research timelines while reducing experimental cost and risk. Enabled enterprise-scale access to advanced scientific computing through standardized cloud environments.